Bayer reported 39.55B in Current Assets for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Current Assets Change
Akzo Nobel AKZA:NA 7.03B 60M
Alcon AG ALC:SW 4.79B 97.27M
Amarin AMRN:US $ 719.12M 53.5M
Arkema AKE:FP € 5312M 353M
Artemis Alpha ATS:LN 563.2M 438.4M
AstraZeneca AZN:LN 20.92B 1.73B
BASF BAS:GR 43.35B 625M
Bayer BAYN:GR 39.55B 1.3B
Corteva Inc CTVA:US $ 14.76B 1.11B
Covestro 1COV:GR 7.43B 146M
Essilor EI:FP 10.64B 1.44B
Fresenius FRE:GR € 18818M 816M
Fresenius Medical Care FME:GR € 8105M 65.61M
Genmab GEN:DC 25.49B 2.32B
Givaudan GIVN:VX 3.94B 536M
GlaxoSmithKline GSK:LN 5418.8B 2520B
Hikma Pharmaceutical HIK:LN 176.1B 21.32B
Johnson Matthey JMAT:LN 418.4B 60.7B
Linde LIN:GR 11.27B 985M
Lonza Group LONN:SW 5.7B 251M
Merck MRK:GR € 12416M 1331M
Novartis NOVN:VX 38.14B 906M
Nutrien Ltd NTR:CN C$ 18.66B 1.63B
Ppg Industries PPG:US $ 7756M 129M
SAP SAP:GR 20.12B 3.25B
Solvay SOLB:BB € 9015M 500M
Umicore UMI:BB 7.06B 1.11B